KMTS Kestra Medical Technologies Ltd.

Price (delayed)

$20.53

Market cap

$1.2B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.32

Enterprise value

$951.45M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 29
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 12

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and ...

Highlights
The gross profit has soared by 127% year-on-year and by 18% since the previous quarter
KMTS's equity has surged by 76% since the previous quarter
Kestra Medical Technologies's net income has plunged by 69% YoY and by 9% from the previous quarter
Kestra Medical Technologies's debt has increased by 3.9% from the previous quarter

Key stats

What are the main financial stats of KMTS

KMTS stock price

How has the Kestra Medical Technologies stock price performed over time
Intraday
9.09%
1 week
-3.39%
1 month
-0.1%
1 year
3.74%
YTD
-22.59%
QTD
3.01%

Financial performance

How have Kestra Medical Technologies's revenue and profit performed over time
Revenue
$83.72M
Gross profit
$40.81M
Operating income
-$143.61M
Net income
-$143.89M
Gross margin
48.8%
Net margin
-171.9%
The gross profit has soared by 127% year-on-year and by 18% since the previous quarter
KMTS's operating income has dropped by 83% year-on-year and by 11% since the previous quarter
Kestra Medical Technologies's net income has plunged by 69% YoY and by 9% from the previous quarter
Kestra Medical Technologies's revenue has surged by 59% YoY and by 13% QoQ

Price vs fundamentals

How does KMTS's price correlate with its fundamentals

Growth

What is Kestra Medical Technologies's growth rate over time

Valuation

What is Kestra Medical Technologies stock price valuation
P/E
N/A
P/B
4.16
P/S
13.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.36
Kestra Medical Technologies's EPS has increased by 31% YoY and by 16% QoQ
KMTS's equity has surged by 76% since the previous quarter
The price to book (P/B) is 38% lower than the last 4 quarters average of 6.1
Kestra Medical Technologies's revenue has surged by 59% YoY and by 13% QoQ
The stock's price to sales (P/S) is 13% less than its last 4 quarters average of 14.5

Efficiency

How efficient is Kestra Medical Technologies business performance
Kestra Medical Technologies's ROE has soared by 65% from the previous quarter
The company's return on assets rose by 43% YoY and by 18% QoQ
KMTS's return on invested capital is down by 37% year-on-year
Kestra Medical Technologies's return on sales has decreased by 11% YoY but it has increased by 2.5% QoQ

Dividends

What is KMTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KMTS.

Financial health

How did Kestra Medical Technologies financials performed over time
KMTS's total assets has soared by 54% from the previous quarter
Kestra Medical Technologies's quick ratio has increased by 36% QoQ
Kestra Medical Technologies's debt is 84% less than its equity
The debt to equity has soared by 194% YoY but it is down by 41% from the previous quarter
KMTS's equity has surged by 76% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.